Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Somerset Therapeutics, LLC

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on Feb 8, 2019.

Shortage details

Status
Current
Company
Somerset Therapeutics, LLC
Package NDC
70069-021-25
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)
Initial Posting
Feb 8, 2019

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.